EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unlocking the potential of bispecific ADCs for targeted cancer therapy

Hongye Zeng, Wenjing Ning, Xue Liu, Wenxin Luo, Ningshao Xia

Frontiers of Medicine · 2024-08 · 18 (4) · 597-621

DOI: 10.1007/s11684-024-1072-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers of Medicine, online erschienen am 23.07.2024. Verfasst von Hongye Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102…. Hauptthemen laut MEDLINE: Neoplasms, Antibodies, Bispecific, Immunoconjugates. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 226 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntibodies, BispecificImmunoconjugatesHumansAntineoplastic AgentsDrug Delivery SystemsMolecular Targeted Therapy

Stichwörter der Autor:innen

antibody–drug conjugatebispecific ADCbispecific antibodycancer

Substanzen

Antibodies, BispecificImmunoconjugatesAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China.
  • National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Innovation Platform for Industry-Education Integration…
  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China. liuxue1108@xmu.edu.cn.
  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, 361102, China. wxluo@xmu.edu.cn.

Zitieren

APA

Zeng, H., Ning, W., Liu, X., Luo, W., & Xia, N. (2024). Unlocking the potential of bispecific ADCs for targeted cancer therapy. Frontiers of Medicine, 18(4), 597-621. https://doi.org/10.1007/s11684-024-1072-8

Vancouver

Zeng H, Ning W, Liu X, Luo W, Xia N. Unlocking the potential of bispecific ADCs for targeted cancer therapy. Frontiers of Medicine. 2024;18(4):597-621. doi:10.1007/s11684-024-1072-8

BibTeX
@article{Zeng2024,
  author = {Zeng, Hongye and Ning, Wenjing and Liu, Xue and Luo, Wenxin and Xia, Ningshao},
  title = {Unlocking the potential of bispecific ADCs for targeted cancer therapy},
  journal = {Frontiers of Medicine},
  year = {2024},
  volume = {18},
  number = {4},
  pages = {597--621},
  doi = {10.1007/s11684-024-1072-8}
}
Kostenlos starten →